Apyx Medical Sees FY24 Revenues Of $49.7M-$52.9M Vs. $49.94M Estimate, Representing Decrease Of Approximately 5% Compared To Growth Of Approximately 1% YoY
Portfolio Pulse from Benzinga Newsdesk
Apyx Medical projects its FY24 revenues to be between $49.7M and $52.9M, which is around the $49.94M estimate but represents a decrease of about 5% compared to the previous year's growth of approximately 1%.
May 09, 2024 | 11:27 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Apyx Medical anticipates FY24 revenues to fall between $49.7M and $52.9M, slightly aligning with the $49.94M estimate but showing a 5% decrease from the prior year's growth.
The projected decrease in revenue for FY24 compared to the previous year's growth indicates a potential negative impact on Apyx Medical's stock price in the short term. This outlook, especially being close to the estimate but showing a decline, could lead to investor concern over the company's growth trajectory and profitability, potentially affecting stock performance negatively.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100